104 related articles for article (PubMed ID: 12866297)
41. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
42. Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression.
Lamy PJ; Verjat T; Servanton AC; Paye M; Leissner P; Mougin B
Am J Clin Pathol; 2007 Sep; 128(3):404-13. PubMed ID: 17709314
[TBL] [Abstract][Full Text] [Related]
43. Clinical relevance of prognostic factors in axillary node-negative breast cancer.
Thomssen C; Jänicke F; Harbeck N
Onkologie; 2003 Oct; 26(5):438-45. PubMed ID: 14605459
[TBL] [Abstract][Full Text] [Related]
44. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.
Schmidt M; Lewark B; Kohlschmidt N; Glawatz C; Steiner E; Tanner B; Pilch H; Weikel W; Kölbl H; Lehr HA
Breast Cancer Res; 2005; 7(2):R256-66. PubMed ID: 15743506
[TBL] [Abstract][Full Text] [Related]
45. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
46. Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
[TBL] [Abstract][Full Text] [Related]
47. Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens.
Thomssen C; Harbeck N; Dittmer J; Abraha-Spaeth SR; Papendick N; Paradiso A; Lisboa B; Jaenicke F; Schmitt M; Vetter M
J Natl Cancer Inst; 2009 Jul; 101(14):1028-9. PubMed ID: 19535782
[No Abstract] [Full Text] [Related]
48. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
[TBL] [Abstract][Full Text] [Related]
49. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
50. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
[TBL] [Abstract][Full Text] [Related]
51. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
52. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
53. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
55. [Relation between angiogenesis, fibrinolysis and invasion/metastasis in breast cancer].
Xiao JP; Yu XF; Xu XQ; Zhang L; He FR; Qi Y; Chen YH; Xia WH
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):226-8. PubMed ID: 15949423
[TBL] [Abstract][Full Text] [Related]
56. [Interview with private lecturer Dr. med. Nadia Harbeck, Munich. Prognostic markers guide therapy (interview by Jochen Aumiller)].
Harbeck N
MMW Fortschr Med; 2003 Jan; 145(3-4):8, 10. PubMed ID: 12619225
[No Abstract] [Full Text] [Related]
57. Study indicates utility for new breast cancer prognostic marker.
Stephenson J
JAMA; 2001 Jun; 285(24):3077-8. PubMed ID: 11427119
[No Abstract] [Full Text] [Related]
58. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer.
Yamashita J; Ogawa M; Sakai K
Surgery; 1995 Jun; 117(6):601-8. PubMed ID: 7778023
[TBL] [Abstract][Full Text] [Related]
59. Cytologic grading in relation to the clinical stage of the breast cancer.
Svejda J; Kudlicková Z
Neoplasma; 1983; 30(4):493-6. PubMed ID: 6888611
[TBL] [Abstract][Full Text] [Related]
60. [Difficulties encountered in the evaluation of prognostic criteria of breast cancer: apropos of the experience of the René Huguenin center].
Spyratos F; Le Doussal V; Tubiana-Hulin M; Hacene K; Rouessé J
Bull Acad Natl Med; 1994 Mar; 178(3):495-506; discussion 506-7. PubMed ID: 8076189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
